CSTL
CASTLE BIOSCIENCES INC
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$35.34
−3.92%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.82x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.30x
- Price / sales
- 3.02x
- Price / cash flow
- 25.32x
Enterprise value
- Enterprise value
- $849.5M
- EV / sales
- 2.38x
- EV / EBITDA
- -262.50x
- EV / EBIT
- -26.46x
- Market cap
- $1.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026